MARKET

EYEN

EYEN

Eyenovia Inc
NASDAQ
0.9297
-0.0304
-3.17%
After Hours: 0.9100 -0.0197 -2.12% 19:45 04/07 EDT
OPEN
0.9400
PREV CLOSE
0.9601
HIGH
0.9600
LOW
0.9000
VOLUME
56.56K
TURNOVER
--
52 WEEK HIGH
124.80
52 WEEK LOW
0.9000
MARKET CAP
1.95M
P/E (TTM)
-0.0161
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EYEN last week (0331-0404)?
Weekly Report · 16h ago
Eyenovia Inc <EYEN.OQ> expected to post a loss of $7.20 a share - Earnings Preview
Reuters · 6d ago
Eyenovia Delays Yearly Report Filing
TipRanks · 03/31 22:47
EYENOVIA: SEES SIGNIFICANT NON-CASH IMPAIRMENT FOR FY ENDED DEC 2024 ON STRATEGIC ALTERNATIVES UNCERTAINTY - SEC FILING
Reuters · 03/31 20:22
Weekly Report: what happened at EYEN last week (0324-0328)?
Weekly Report · 03/31 11:43
Weekly Report: what happened at EYEN last week (0317-0321)?
Weekly Report · 03/24 11:30
Eyenovia Inc <EYEN.OQ> expected to post a loss of $7.20 a share - Earnings Preview
Reuters · 03/21 20:08
Eyenovia Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones · 03/21 12:26
More
About EYEN
More
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Recently
Symbol
Price
%Change

Webull offers Eyenovia Inc stock information, including NASDAQ: EYEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EYEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EYEN stock methods without spending real money on the virtual paper trading platform.